These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2305941)
1. Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases. Archer SG; Gray BN Am J Surg; 1990 Mar; 159(3):325-9. PubMed ID: 2305941 [TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases. Archer S; Gray B Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194 [TBL] [Abstract][Full Text] [Related]
3. The significance of portal vein chemotherapy for liver micrometastases: an experimental study of a rat model. Ishida H; Iwama T; Mishima Y Surg Today; 1994; 24(10):900-5. PubMed ID: 7894188 [TBL] [Abstract][Full Text] [Related]
4. Tumor and liver drug uptake following hepatic artery and portal vein infusion. Sigurdson ER; Ridge JA; Kemeny N; Daly JM J Clin Oncol; 1987 Nov; 5(11):1836-40. PubMed ID: 3681370 [TBL] [Abstract][Full Text] [Related]
5. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer. Gerard A; Pector JC; Bleiberg H Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873 [TBL] [Abstract][Full Text] [Related]
6. Bromodeoxyuridine uptake by early liver metastases in rats: a comparison of the hepatic artery and portal vein infusion routes. Ishida H; Iwama T; Yoshinaga K; Gonda T; Idezuki Y Surg Today; 1998; 28(8):822-9. PubMed ID: 9719004 [TBL] [Abstract][Full Text] [Related]
8. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study. Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781 [TBL] [Abstract][Full Text] [Related]
9. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis]. Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446 [TBL] [Abstract][Full Text] [Related]
10. Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model. Flowerdew AD; Richards HK; Taylor I Gut; 1987 Oct; 28(10):1201-7. PubMed ID: 3678948 [TBL] [Abstract][Full Text] [Related]
11. Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial. Hafström L; Engarås B; Holmberg SB; Gustavsson B; Jönsson PE; Lindnér P; Naredi P; Tidebrant G Cancer; 1994 Nov; 74(10):2749-56. PubMed ID: 7954233 [TBL] [Abstract][Full Text] [Related]
12. [An experimental study on portal infusion of 5-fluorouracil]. Ishida H; Iwama T; Nishioka Y; Endo S; Okubo Y; Imajo M; Otomo M; Mishima Y Gan To Kagaku Ryoho; 1991 Aug; 18(11):1884-8. PubMed ID: 1877831 [TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061 [TBL] [Abstract][Full Text] [Related]
14. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group]. Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A; Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427 [TBL] [Abstract][Full Text] [Related]
15. A comparative study on effects of doxorubicin alone or mixed with lipiodol given through the hepatic artery or portal vein for liver tumors in rats. Utsunomiya T; Kanematsu T; Matsumata T; Shirabe K; Yamagata M; Sugimachi K Oncology; 1994; 51(3):276-81. PubMed ID: 8196912 [TBL] [Abstract][Full Text] [Related]
16. [An experimental study on portal infusion of 5-fluorouracil (the second report)]. Ishida H; Iwama T; Ide A; Nihei Z; Imajo M; Mishima Y Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1532-5. PubMed ID: 1530301 [TBL] [Abstract][Full Text] [Related]
17. [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer]. Adachi W; Watanabe H; Yazawa K; Koide N; Koike S; Mihara M; Nakata S; Kajikawa S; Kuroda T; Amano J Gan To Kagaku Ryoho; 1998 Apr; 25(5):697-703. PubMed ID: 9571967 [TBL] [Abstract][Full Text] [Related]
18. Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer. Almersjö O; Gustavsson B; Hafström L Ann Chir Gynaecol; 1976; 65(1):27-32. PubMed ID: 1032874 [TBL] [Abstract][Full Text] [Related]
19. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping. el Hag IA; Jakobsson B; Jönsson PE; Stenram U Res Exp Med (Berl); 1990; 190(3):183-92. PubMed ID: 1695018 [TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental liver metastases in the rat by continuous intraportal infusion of 5-fluorouracil and heparin: a pilot study. Nagawa H; Paris P; Chauffert B; Martin F Anticancer Drugs; 1990 Dec; 1(2):149-56. PubMed ID: 2131047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]